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Live-cell monitoring of periodic gene expression 
in synchronous human cells identifies Forkhead 
genes involved in cell cycle control
Gavin D. Granta, Joshua Gamsbya, Viktor Martyanova, Lionel Brooks 3rda, Lacy K. Georgea, 
J. Matthew Mahoneya, Jennifer J. Lorosa,b, Jay C. Dunlapa, and Michael L. Whitfielda
aDepartment of Genetics and bDepartment of Biochemistry, Geisel School of Medicine at Dartmouth, Hanover, 
NH 03755
ABSTRACT We developed a system to monitor periodic luciferase activity from cell cycle–
regulated promoters in synchronous cells. Reporters were driven by a minimal human E2F1 
promoter with peak expression in G1/S or a basal promoter with six Forkhead DNA-binding 
sites with peak expression at G2/M. After cell cycle synchronization, luciferase activity was 
measured in live cells at 10-min intervals across three to four synchronous cell cycles, allowing 
unprecedented resolution of cell cycle–regulated gene expression. We used this assay to 
screen Forkhead transcription factors for control of periodic gene expression. We confirmed 
a role for FOXM1 and identified two novel cell cycle regulators, FOXJ3 and FOXK1. Knock-
down of FOXJ3 and FOXK1 eliminated cell cycle–dependent oscillations and resulted in de-
creased cell proliferation rates. Analysis of genes regulated by FOXJ3 and FOXK1 showed 
that FOXJ3 may regulate a network of zinc finger proteins and that FOXK1 binds to the pro-
moter and regulates DHFR, TYMS, GSDMD, and the E2F binding partner TFDP1. Chromatin 
immunoprecipitation followed by high-throughput sequencing analysis identified 4329 ge-
nomic loci bound by FOXK1, 83% of which contained a FOXK1-binding motif. We verified 
that a subset of these loci are activated by wild-type FOXK1 but not by a FOXK1 (H355A) 
DNA-binding mutant.
INTRODUCTION
The cell cycle, which governs the timing and progression of DNA 
replication (S phase) and mitosis (M phase), is one of the most tightly 
regulated cellular processes. Because misregulation can lead to 
catastrophic cellular events such as programmed cell death or can-
cer, determining the key regulators and pathways controlling peri-
odic, cell cycle–dependent gene expression is critical. Cell cycle–
regulated gene expression has been studied extensively by DNA 
microarray (Cho et al., 2001; Whitfield et al., 2002; Bar-Joseph et al., 
2008), luciferase reporter assays (Hwang et al., 1995), and both time-
lapse and still-image microscopy (Stacey and Hitomi, 2008; Kaida 
et al., 2011). Although these assays can provide extraordinary levels 
of detail with regard to the number of genes measured, they are too 
costly and time-consuming to use as a screening strategy for genes 
that affect the regulation of periodic gene expression. To study ge-
netic interactions between regulators and periodic gene expression, 
we developed a system to measure cell cycle–driven luciferase ex-
pression in living cells over multiple synchronous cell cycles in real 
time. We then used this system in conjunction with RNA interference 
(RNAi) to identify novel regulators of cell cycle progression.
The ability to follow promoter-regulated luciferase activity in live 
cells has been used successfully to probe the molecular nature of 
both circadian rhythms (Welsh et al., 2004) and cell division in yeast 
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2008). The combination of E2F1 promoter autoregulation and E2F7 
and E2F8 repression restricts the promoter activity to G1/S.
To exploit the well-characterized, cell cycle–controlled oscillatory 
behavior of E2F1 at G1/S and FOXM1 at G2/M, we used constructs 
with either a minimal E2F1 promoter or FOX DNA consensus bind-
ing sites (Furuyama et al., 2000) driving luciferase expression. Using 
cell cycle synchronization protocols combined with selective small 
interfering RNA (siRNA) knockdowns, we followed the G1/S or G2/M 
reporters and identified two genes necessary for proper oscillation 
of cell cycle–regulated gene expression in human cells, FOXJ3 and 
FOXK1 (myocyte nuclear factor). We identified target genes regu-
lated by FOXJ3 and FOXK1. We also identified the genomic loci 
bound by FOXK1 with chromatin immunoprecipitation followed by 
short read sequencing (ChIP-seq), which showed that FOXK1 might 
have a direct role in regulating the transcription of key cell cycle ef-
fectors. We identified a FOXK1 DNA motif present in 81.6% of the 
intersecting ChIP-seq peaks identified by MACS, and we show that 
select ChIP-seq peaks are responsive to FOXK1 in the live-cell lu-
ciferase reporter assay. These results show that FOXK1 regulates an 
expansive network of genes, including many that are critical for cell 
cycle progression, most notably DHFR, TYMS, GSDMD, and 
TFDP1.
RESULTS
We designed experiments to identify Forkhead transcription factors 
that contribute to the periodic oscillation of cell cycle–regulated 
genes. We optimized thymidine-thymidine (thy-thy) and thymidine-
nocodazole (thy-noc) cell cycle synchronizations (Whitfield et al., 
2002) in U2OS cells, a human osteosarcoma line widely used for cell 
cycle studies (Fu et al., 2008; Laoukili et al., 2008). To easily and in-
expensively monitor cell cycle progression in living cells across mul-
tiple, synchronous cell cycles, we developed stable cell lines that 
expressed cell cycle–regulated luciferase reporters with peak activ-
ity in either G1/S or G2/M.
Development of real-time cell cycle reporter assay 
for periodic gene expression
Previous studies reported that FOXM1 activity oscillates in a cell 
cycle–dependent manner (Laoukili et al., 2005, 2008; Fu et al., 
2008). To report FOXM1 activity, we used a construct that has six 
Forkhead DNA-binding domains (6xDB) that drive expression of lu-
ciferase. Because estrogen receptors (ERs) localize to the nucleus 
upon ligand binding and this property can be exploited to artificially 
shuttle proteins to the nucleus (Chandriani et al., 2009), we designed 
a construct that expresses a fusion of FOXM1 and ER (FOXM1-ER). 
We then transiently transfected U2OS cells with both the 6xDB and 
FOXM1-ER constructs and confirmed by chromatin immunoprecipi-
tation that FOXM1 is bound to the FOX-specific consensus se-
quences after addition of 4-hydroxytamoxifen (4OHT; Supplemental 
Figure S1D, inset). Addition of ER ligand 4OHT induced nuclear 
translocation of the FOXM1-ER fusion protein, which elicited an in-
crease of luciferase activity beginning between 7.5 and 9 h, with 
peak luciferase expression around 34 h (Supplemental Figure S1D). 
Luciferase activity increased approximately eightfold in the 4OHT-
treated cells compared with the vehicle-only negative control cells. 
Thus FOXM1 binds directly to FOX-specific DNA-binding sites and 
activates the 6xDB construct in our U2OS system.
After synchronization of U2OS cells stably expressing the 6xDB 
reporter at G1/S by thy-thy synchronization, FOXM1 displays peak 
levels and increased phosphorylation in late G2 (Figure 1A, top), and 
luciferase activity peaks concomitantly (Figure 1B). As expected, 
FOXM1 phosphorylation peaks during G2 before FOXM1 is 
show that progression through mitosis is independent of the circa-
dian rhythm in Rat-1 fibroblasts (Yeom et al., 2010). In the case of 
mammalian circadian rhythms, cells transfected with a circadian-
regulated promoter driving luciferase are synchronized, and lu-
ciferase activity is followed over time in a luminometer (Gamsby 
et al., 2009). In addition, circadian rhythms can be followed with this 
method in cells or tissue isolated from transgenic mice containing 
clock genes fused to luciferase at their endogenous loci (Yoo et al., 
2004). Furthermore, RNAi has been used with this system to un-
cover novel components of the mammalian molecular clock (Zhang 
et al., 2009).
Measurement of luciferase activity in real time allows for simpler 
data collection and for greater accuracy, as the sampling intervals 
are more frequent than with other methods. Furthermore, since the 
measurements are nondestructive, the readings are from the same 
cells throughout the experiment, thus removing the variability of 
sample-to-sample comparison and greatly reducing the number of 
replicates needed. Because the cells are viable during data collec-
tion, drug treatments with agents such as DNA-damage inducers 
are possible throughout the experiment, allowing for great flexibility 
in experimental design (Gamsby et al., 2009). In addition, since lu-
ciferase remains bound to oxyluciferin after the light-emitting reac-
tion (Lemasters and Hackenbrock, 1977) and the media contains an 
excess of luciferin, the readings obtained report the activity of newly 
synthesized luciferase, giving a clearer snapshot of reporter activity.
Forkhead Box (FOX) genes form a family of transcription factors 
found in species from yeast to human and are involved in a number 
of different cellular processes, including cell cycle progression, or-
gan development, and oxidative stress responses (Huang and 
Tindall, 2007). The FOX family of transcription factors comprises 
>30 genes in humans, all of which contain a monomeric DNA-bind-
ing domain (Kaestner et al., 2000).
The transcription factor FOXM1 is known to regulate gene tran-
scription during the transition from G2 to M phase of the cell cycle 
and to be overexpressed in cancer cells (Wierstra and Alves, 2007). 
RNAi-mediated knockdown in U2OS or BT-20 human cells results in 
decreased mitotic indexes and a concomitant increase in the num-
ber of cells in G2 (Laoukili et al., 2005; Wonsey and Follettie, 2005). 
In G2, FOXM1 up-regulates the expression of Cdc25B, cyclin B1, 
Aurora B kinase, Plk1, CENPA, CENPB, and survivin. In addition, 
FOXM1 is progressively phosphorylated by a number of kinases, 
including PLK1 and cyclin B/cdk1 complexes (Fu et al., 2008), as well 
as by cyclin A/CDK2 or cyclin E/CDK2 complexes (Wierstra and 
Alves, 2007), which then leads to its degradation by the APC/C after 
targeting by CDH1 at the end of mitosis (Laoukili et al., 2008). These 
phosphorylation events restrict the period of FOXM1 DNA-binding 
activity to the G2 and M phases of the cell cycle. Given this, a re-
porter driven by a synthetic promoter that is responsive to FOXM1 
activity will accurately report the G2/M-specific activity of FOXM1.
E2F1 is a member of the E2F family of transcription factors, which 
control the expression of genes involved in apoptosis, differentiation, 
DNA synthesis, and mitosis (Shibutani et al., 2008). E2F1 is specifically 
involved in the transition from G1 to S phase of the cell cycle (Johnson 
et al., 1994). Of the many regulatory mechanisms that control E2F1 
activity during the cell cycle, two of the best characterized are the 
binding of E2Fs to the retinoblastoma family of proteins and cell cycle 
phase–specific degradation (Marti et al., 1999). In addition, cell cycle 
regulation of the E2F1 promoter restricts expression to the correct 
cell cycle phase. The E2F1 promoter is autoregulated by active E2F1 
during G1/S (Johnson et al., 1994), driving a rapid increase of active 
E2F1. After the period of E2F1 activity is complete, E2F7 and E2F8 
bind to and repress the E2F1 promoter (Li et al., 2008; Zalmas et al., 
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that the oscillations in the hE2F1 cell line are reporting late G1 and 
early S phase in U2OS cells.
As a negative control for the luciferase reporters, we gener-
ated stably transfected U2OS cells with either no promoter (pGL3-
Basic with no insertions) or a constitutive promoter (pGL3-Control; 
Supplemental Figure S2). No pGL3-Basic or pGL3-Control cell 
lines showed significant oscillations with periods close to that of 
the cell cycle, confirming that the oscillations in 6xDB and hE2F1 
cell lines are not caused by cell line production or synchronization 
method.
Numerous Forkhead genes are involved in proper 
cell cycle regulation
The ability to monitor simultaneously and with precision the differ-
ent cell cycle stages suggested to us that this system would be use-
ful in screening potential cell cycle regulators. As a proof of princi-
ple, we treated 6xDB and hE2F1 cells with siRNAs specific to FOXM1 
and then synchronized the treated cells in G1/S with a thy-thy block 
(Supplemental Figure S1). Knowing that cells treated with siRNAs 
targeting FOXM1 have aberrant mitosis and undergo mitotic catas-
trophe (Wierstra and Alves, 2007), we anticipated dampened or lost 
oscillations in both markers, assuming the degree of knockdown 
was sufficient; this was observed (Figure 3, A and B). Empowered by 
these positive controls and the lack of cell cycle effects in negative 
controls (see Supplemental Figure S2, A and B), we screened siR-
NAs against five FOX genes. Four were implicated in cell cycle con-
trol in one of four genome-wide RNAi screens for cell cycle defects 
(FOXA2, FOXJ3, FOXK1, and FOXL2; Mukherji et al., 2006; Root 
et al., 2006; Kittler et al., 2007; Rines et al., 2008), and one showed 
periodic mRNA expression during the cell cycle in one of three ge-
nome-wide mRNA profiling experiments for cell cycle-regulated 
genes (FOXP1; G.D.G., L.K.G., and M.L.W., unpublished data). 
degraded after mitosis (Figure 1A, hours 18 and 34). Given that 
phosphorylation of FOXM1 is required for its activity, these data also 
suggest that active FOXM1 is driving FOX DNA consensus site ex-
pression peaks, since the phosphorylation profile of FOXM1 is in 
phase with peak activity of 6xDB. Furthermore, the luciferase re-
porter shows minimal activity in late G1 and early to mid S phase, 
which is consistent with previously reported findings (Luscher-Firzlaff 
et al., 2006). The two peaks of luciferase activity correspond to G2/M 
phase of sequential cell cycles as determined by fluorescence-acti-
vated cell sorting (FACS) analysis (Figure 1C). A gradual dampening 
of the rhythm occurs over time as the cell population loses synchrony, 
as evidenced by increased standard error of the mean (SE; Figure 
1B) and a decrease in the maximal percentage of G2/M cells in the 
second cell cycle (Figure 1C). These data show that peak expression 
of the 6xDB reporter faithfully reports late G2 and M phase in the 
U2OS cell cycle.
Precise analysis of cell cycle progression requires markers at 
more than one phase, so we also generated cells that stably express 
luciferase under the control of a minimal human E2F1 promoter 
(hE2F1) to report the G1/S transition. Cells were analyzed by West-
ern blot and luciferase activity in a manner similar to FOXM1. Peak 
expression of E2F1 occurs at 2 and 22 h after release from a thy-thy 
block as seen via Western blot (Figure 1D), which corresponds to 
peak luciferase activity (Figure 1E) and with the G1 phase of the cell 
cycle, as determined by FACS profiling (Figure 1F).
To confirm the cell cycle dependence of the oscillations in E2F1 
and FOXM1, we used a thy-noc synchronization method to arrest 
the cells in M phase instead of G1/S (Figure 2). As expected, the two 
synchronization methods yield peak luciferase activity that is anti-
phasic, a result of the two synchronization methods blocking at two 
opposing points in the cell cycle. Both synchronization methods 
yield cell cycle periods between 18 and 22 h. These data indicate 
FIGURE 1: Synchronous U2OS cells show periodic oscillation of G1/S and G2/M luciferase reporters. (A) Anti-FOXM1 
Western blot in synchronous 6xDB U2OS cells shows periodic expression and phosphorylation of FOXM1 protein. 
Samples were taken every 2 h after release from the second thymidine block. Peak FOXM1 phosphorylation occurs at 
12–14 and 30–32 h after release. GAPDH is shown as a loading control. (B) Baseline-subtracted luciferase activity in cells 
expressing 6xDB peaks at 12–14 and 30–32 h. Luciferase activity was read every 10 min from each of four replicate 
plates. Error bars represent the SE of the quadruplicate samples. (C) The percentage of cells in G1 and G2/M based on 
PI staining. FlowJo was used to calculate the percentage of cells in each phase. (D) Western blot showing E2F1 levels in 
synchronous hE2F1 U2OS cells. Samples were taken every 2 h after release from the second thymidine block. GAPDH is 
shown as a loading control. Arrow indicates the E2F1 band. (E) Baseline-subtracted luciferase activity in cells expressing 
hE2F1-luciferase (hE2F1-luc) peaks at 20–24 h postrelease. Error bars represent the SE of quadruplicate samples. (F) The 
percentage of cells in G1 or G2/M based on PI staining. Cells were plated and treated in parallel for A–C and D–F.
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to cell cycle arrest and not to a direct interaction between the re-
porter and FOXK1 proteins, since FOXK1 does not appear to target 
PLK1 directly (see ChIP-seq data presented later).
Consistent with this, all siRNAs against FOXJ3, FOXK1, or 
FOXM1 resulted in significantly reduced proliferation rates com-
pared with controls (Figure 5). A cell viability assay revealed no no-
ticeable increases in dead cells between the control and the siRNA-
treated cells, indicating that the decrease in cell numbers reflects a 
decrease in proliferation rate. Disruption of cell cycle progression by 
these FOX-specific siRNAs was further confirmed by FACS analysis 
of propidium iodide (PI)–stained cells, which revealed an increase in 
the number of cells in G1 (Figure 5A). These data indicate that in 
addition to FOXM1, the Forkhead Box transcription factors FOXJ3 
and FOXK1 have important roles in regulating cell proliferation. This 
also suggests that an extensive network of Forkhead transcription 
factors regulates cell cycle progression.
Transcriptional targets of FOXJ3 and FOXK1
To identify potential gene targets of FOXJ3 and FOXK1, we per-
formed three independent siRNA knockdowns for these two genes 
in asynchronous U2OS cells. As a negative control, we used an 
siRNA that does not target any known cellular mRNAs (siGENOME 
Non-Targeting siRNA #2). We collected time points before siRNA 
treatment (0 h) and at 12, 24, 48, and 72 h after knockdown. We 
prepared RNA from each time point and analyzed it using DNA mi-
croarray hybridization. We selected 1651 genes that changed at 
least 2.14-fold from the 0 time point in at least three samples and 
clustered them hierarchically (Figure 6A).
Multiple clusters of coordinately regulated genes were evident 
after siRNA knockdown. The genes showing the most consistent 
decrease in expression were those associated with cell division. As 
expected, these genes showed decreased expression in both 
FOXJ3 and FOXK1 treatments, and there is an enrichment of well-
characterized cell cycle–regulated genes (Figure 6E). These include 
genes known to cause cell cycle defects after knockdown (Mukherji 
et al., 2006; Root et al., 2006; Kittler et al., 2007; Rines et al., 2008), 
as well as genes expressed in S (RRM2) and G2/M phases (CENPE, 
PLK1, and STK6; Whitfield et al., 2002). Of the 52 genes with 
decreased expression in this cluster, 35 (69%) were cell cycle regu-
lated in HeLa cells (Whitfield et al., 2002). Analysis of the 52 genes 
in this cluster by the Database for Annotation, Visualization and In-
tegrated Discovery (DAVID; Dennis et al., 2003; Huang da et al., 
2009) showed enrichment for genes associated with cell cycle–spe-
cific processes (Supplemental Table S1). A second general group of 
genes included the immediate early genes that are increased by 
serum stimulation (Iyer et al., 1999; Figure 6C) and decrease with 
time after treatment in both the siRNA knockdowns and the mock 
treatment.
To identify genes that might be specifically regulated by either 
FOXJ3 or FOXK1, we examined the data for genes whose expres-
sion levels changed due to the knockdown of one Forkhead but not 
the other. As expected, FOXJ3 mRNA levels were decreased by the 
siRNA specific for FOXJ3 but not by the siRNA for FOXK1 or the 
control siRNA. Examination of genes that cluster with FOXJ3 shows 
that 9 of 32 genes are uncharacterized zinc finger proteins (Figure 
6D), whereas others include a ring finger protein (RNF138) and a 
putative RNA-binding protein (RBM25). This suggests that FOXJ3 
might have a role in regulating this subset of zinc finger DNA and/
or RNA-binding proteins that might be involved in cell cycle pro-
gression (Supplemental Table S1). We also uncovered a group of 
genes (Figure 6B) that showed increased expression after FOXJ3 
knockdown and decreased expression in the FOXK1 knockdown, 
Overlap between the different RNAi screens and mRNA expression 
data was minimal, resulting in each gene being identified in only a 
single screen. FOXM1, a known regulator of cell cycle gene expres-
sion, was only identified in Whitfield et al. (2002).
In independent experiments, knockdown of FOXJ3 and FOXK1 
greatly decreased the cell cycle–dependent oscillations in both 
6xDB and hE2F1 cell lines (Figure 3, E–L). FOXL2 was found not to 
be expressed in U2OS cells and, consistent with this finding, had no 
cell cycle phenotype (unpublished data). Quantitative PCR demon-
strated knockdown efficiencies of 90 and 60% of wild-type gene 
expression levels for FOXJ3 and FOXK1, respectively, showing that 
even a partial loss of function significantly affected periodic gene 
expression (Figure 3M). Knockdown of the remaining Forkhead pro-
teins gave intermediate phenotypes; detailed characterization will 
be reported elsewhere.
We then used a human PLK1 promoter luciferase reporter con-
struct to show that loss of G2/M oscillations also occurred with an 
endogenous human G2/M promoter. U2OS cells stably expressing 
this reporter faithfully reproduced the same periodic, G2/M-specific 
oscillation and phasing of luciferase activity as the synthetic 6xDB 
Forkhead Box promoter construct (Figure 4A). RNAi knockdown with 
the two independent siRNAs against FOXJ3 (Figure 4, B and C) and 
FOXK1 (Figure 4, D and E) shows a loss of cell cycle phase–specific 
luciferase activity. This suggests that loss of G2/M oscillations is due 
FIGURE 2: Luciferase activity from hE2F1-Luc and 6xDB-Luc 
reporters are antiphasic after thy-thy and thy-noc synchronizations. 
(A) Baseline-subtracted luciferase activity over 54 h after thy-thy 
synchronization in cells expressing 6xDB-Luc and hE2F1-Luc. Raw data 
are shown as an inset at the upper right. (B) Baseline-subtracted 
luciferase activity in cells expressing hE2F1-Luc and 6xDB-Luc over 
78 h after a thy-noc synchronization. Mean values of quadruplicate 
samples are shown. Raw data are shown as an inset at the upper 
right.
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indicating that these genes might be repressed by FOXJ3 
activity and activated by FOXK1. This set of genes could 
represent indirect FOXK1 targets, although many of these 
genes do not have a clear role in cell cycle regulation. 
However, there is a significant enrichment for proteins 
involved in cell signaling (p = 1.02 × 10−4; Supplemental 
Table S1) as well as secreted, extracellular matrix proteins 
(p = 0.001).
FOXK1 binds to the promoter and regulates 
key cell cycle regulators
To understand how knockdown of FOXK1 results in cell 
cycle arrest, we sought to identify direct targets of FOXK1 
by analyzing the DNA regions bound by endogenous 
FOXK1 by ChIP-seq using two independent antibodies 
against FOXK1 (adequate antibodies were not available 
for FOXJ3). The DNA fragments from each independent 
ChIP were sequenced independently. ChIP-seq of FOXK1 
using the first antibody (AB G22; Santa Cruz Biotechnol-
ogy) resulted in 58 million mapped sequence reads 
(2.1 million unmapped), and ChIP-seq using the second 
antibody (AB134550; Santa Cruz Biotechnology) resulted 
in 65 million mapped reads (2.2 million unmapped; Human 
Genome build 19). Enriched peaks were identified in each 
data set independently using MACS (Zhang et al., 2008; 
Liu et al., 2011; mfold 15, p < 0.001), which resulted in 
7513 peaks in AB G22 and 6225 peaks in AB1344550. For 
a conservative estimate of FOXK1 binding, we focused our 
analysis on those sequences that were found in both ex-
periments. Taking the intersection resulted in 4329 shared 
MACS peaks (Supplemental Table S2). Each includes the 
intersecting DNA region under the peaks, and we refer to 
these as “FOXK1 genomic loci.” We determined the distri-
bution of these 4329 shared FOXK1 binding loci in the ge-
nome using the cis-regulatory element annotation system 
(CEAS; http://liulab.dfci.harvard.edu/CEAS; Zhang et al., 
2008) implemented in Cistrome (www.cistrome.com). The 
4329 genomic loci map to 2865 RefSeq mRNAs represent-
ing 1772 unique human genes. We found significant en-
richment of genomic loci within 3 kb upstream of the tran-
scriptional start site (6.1%, p = 1.7 × 10−53; Figure 7A), and 
36.6% of the genomic loci were found in introns (p = 1.5 × 
10−11). We found 51.7% of the FOXK1 loci in distal inter-
genic regions (defined in this analysis as >3 kb from the 
FIGURE 3: FOXM1, FOXJ3, and FOXK1 are necessary 
for periodic gene expression in synchronous U2OS cells. 
(A–L) Raw luciferase activity levels for cells expressing 
hE2F1-Luc (A, C, E, G, I, K) or 6xDB-Luc (B, D, F, H, J, L) 
treated with the indicated siRNAs and then synchronized by 
a thy-thy arrest (diagramed in Supplemental Figure S1B). 
Luciferase activity was measured every 10 min over 72 h 
after release from the second thymidine arrest. Cells treated 
with siRNAs against FOXJ3, FOXK1, or FOXM1 show 
decreased cell cycle–dependent oscillation of luciferase 
activity relative to control siRNA treatment. All graphs are 
the mean of a minimum of three samples; error bars are SE. 
The y-axes have been set to the same value based on 
luciferase levels in C (hE2F1) and D (6xDB). (M) Relative 
mRNA expression levels for siRNAs to FOXJ3 and FOXK1. 
Control siRNA (Dharmacon siControl #2) expression levels 
have been set to 100%. Expression levels are normalized to 
GAPDH RNA levels.
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FIGURE 4: The cell cycle–dependent oscillations of the human PLK1 
gene promoter are ablated after the knockdown of FOXK1 or FOXJ3. 
Luciferase activity was measured every 10 min over 72 h after release 
from the second thymidine arrest, concomitant with siRNA 
knockdowns as indicated. (A) The cell cycle–associated oscillations of 
FIGURE 5: FOXJ3 and FOXK1 knockdown results in accumulation of 
G1 cells and impaired proliferation. (A) Percentages of cells in each 
cell cycle phase as determined by PI staining. Cells were assayed 72 h 
after siRNA transfection. Both FOXJ3 and FOXK1 cells show an 
increase in the percentage of cells in G1. Error bars are SE from 
triplicate samples. All p values of treated cells compared with 
siControl #2 are <0.05 except FOXK1-1 (p = 0.0538). FlowJo was used 
to calculate the percentages of cells in each phase. (B) A 72-h 
proliferation curve shows a proliferation defect in U2OS cells treated 
with siRNAs targeting FOXJ3 or FOXK1. Error bars are SE of triplicate 
samples. Indicated p values are <0.05 (*), 0.01 (*), or 0.005 (***) when 
compared with the percentage of cells in G1 of the SiControl 
#2–treated cells. (C) Percentage of dead cells, as determined by 
trypan blue staining, from the proliferation curve in B.
luciferase activity driven by the human PLK1 gene promoter after 
transfection with a control siRNA. (B–E) U2OS cells treated with two 
independent siRNAs against FOXJ3 (B, C) or FOXK1 (D, E) showed 
decreased cell cycle–dependent oscillation of luciferase activity. All 
graphs are the mean of at least three samples; error bars are SE. The 
y-axes have been set to the same value based on luciferase levels in A.
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FIGURE 6: Expression profiling of FOXJ3 and FOXK1 siRNA knockdowns in asynchronous U2OS cells. (A) Hierarchical 
clustering of the 1651 genes that changed at least 2.14-fold on three arrays relative to time zero. The first three columns 
are zero time points (blue line), the fourth is the zero average, and each time point for the indicated siRNA is indicated 
by the blue triangle (12, 24, 48, and 72 h). All three experiments were performed in parallel, and therefore the same 
zero time points are used for each siRNA knockdown. (B) Secreted extracellular matrix gene cluster that shows 
increased expression after FOXJ3 knockdown and decreased expression after FOXK1 knockdown. (C) The immediate 
early genes (Iyer et al., 1999; Chang et al., 2004). (D) FOXJ3 cluster shows a decrease in FOXJ3 mRNA, specifically in 
cells treated with the FOXJ3 siRNA, and includes a large number of zinc finger proteins. (E) Cell cycle cluster that shows 
decreased expression in both FOXJ3 and FOXK1 knockdowns. We find that 67.3% of the genes in this cluster are cell 
cycle regulated in HeLa cells.
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FIGURE 7: FOXK1 binds to the promoters of an expansive set of genes critical for cell cycle progression. (A) CEAS 
analysis of the overlapping sequences found in the two antibody ChIP-seq analyses shows an enrichment in promoters 
(3000 base pairs upstream of the transcriptional start site) and a reduction of intronic FOXK1-binding loci relative to 
background. (B) Analysis of the 4329 overlapping FOXKI loci for overrepresented sequence elements identifies two 
significantly enriched FOXK1-like DNA-binding motifs. We find that 83.4% of the FOXK1 genomic loci contain at least 
one of the motifs; 51.3% of the FOXK1 loci contain both motifs. (C) Comparison of all cell cycle–regulated genes from 
Whitfield et al. (2002) with FOXK1 loci shows a higher percentage of occupancy of the promoters of genes with peak 
expression in G1/S and S phase. (D) Comparison of the genes that result in a cell cycle arrest in one of four genome-wide 
siRNA screens (Mukherji et al., 2006; Root et al., 2006; Kittler et al., 2007; Rines et al., 2008) linked to FOXK1 ChIP-seq 
loci shows higher percentage of occupancy in genes that result in an S or G2 phase arrest. (E) Multiple FOXK1-binding 
loci (thick black bars) are found in the promoter and introns of the TFDP1 gene. FOXK1-like DNA-binding motifs found 
in each locus are indicated (thin black bars). (F) A single intronic FOXK1 binding locus with multiple FOXK1-like DNA-
binding motifs (thin black bars) is found in DHFR. Direction of transcription is indicated for each gene. (G) Change in 
gene expression for TFDP1 mRNA in the siRNA knockdown experiment (Figure 6) shows a 2.6-fold drop in TFDP1 
mRNA levels after FOXK1 knockdown. (H) The gene expression data for FOXK1 target genes DHFR, TFDP1, TYMS, and 
GSDMD are shown from the mock and FOXK1 siRNA knockdown. Each is linked to the FOXK1 genomic loci found by 
ChIP-seq. CEAS was used to determine the percentage coverage for each region relative to the TSS of gene models, 
TTS, or within the gene (right). Those that have peak expression levels in G1 or S as determined in Whitfield et al. (2002) 
or that result in a G1- or S-phase arrest when knocked down in one of three genome-wide siRNA screens (Mukherji et al., 
2006; Root et al., 2006; Kittler et al., 2007) are indicated (the full list is available in Supplemental Tables S3 and S4).
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transcription start site [TSS] or transcription termination site [TTS]), 
similar to what would be expected by chance (50%). The percent-
age of FOXK1 loci in 5′ untranslated regions (UTR), coding exons, or 
3′ UTRs of genes was minimal (Figure 7A).
To determine whether the genomic loci bound by FOXK1 were 
enriched for the published FOXK1 consensus sequence motif 
TAAACA (Tsai et al., 2006), we analyzed all 4329 FOXK1 loci for 
enriched binding sites. We found that 83.4% of the FOXK1 loci con-
tain a FOXK1-like consensus motif. Repeat sequences in the ChIP-
seq intersecting sequences were masked using RepeatMasker 
Open-3.0. (www.repeatmasker.org), and significant motifs with high 
similarity to the FOXK1 motif were identified using the MEME Suite 
of programs (Bailey et al., 2009). The MEME-ChIP algorithm (Bailey, 
2011; Machanick and Bailey, 2011) identified 15 motifs that were 
overrepresented in repeat masked FOXK1 genomic loci. These mo-
tifs were then compared with the FOXK1 consensus motif using 
STAMP (Mahony and Benos, 2007). A motif with consensus se-
quence AKAAACA was the best match to the FOXK1 motif (with an 
E value of 1.1 × 10−08) and found in 53% of the FOXK1 loci (Figure 
7B). A second motif with consensus site ACAAAYAY was the second-
best match (with an E value of 3.6 × 10−05) and was found in 81.6% 
of the loci (Figure 7B). When the two motifs are considered together, 
51.3% of the loci contain both motifs, and 83.4% of the loci contain 
at least one of these two motifs.
Genes regulated by FOXK1 genomic loci
We sought to identify genes near FOXK1 genomic loci that are 
cell cycle regulated in HeLa cells (Whitfield et al., 2002) or show 
a cell cycle defect in a collation of genome-wide siRNA screens for 
cell cycle phenotypes (Mukherji et al., 2006; Root et al., 2006; Kittler 
et al., 2007; Rines et al., 2008). To determine whether there was an 
enrichment of FOXK1 loci near cell cycle–regulated genes, we com-
pared the genes associated with FOXK1 loci as determined by Gene 
Centered Annotation (GCA) to the list of cell cycle–regulated genes 
in HeLa cells. We mapped the 1134 cell cycle–regulated clones of 
Whitfield et al. (2002) to 688 unique Entrez Gene IDs. Of these 
genes, 48 (7%) were linked to FOXK1 ChIP-seq loci by GCA (Supple-
mental Table S3). Analysis of the GCA gene models that have FOXK1 
bound shows an increase in the percentage occupancy of promoters 
(a measure of how much of each promoter was recovered by 
ChIP-seq) for genes expressed in G1 and S phases (Figure 7C).
To determine whether there was a similar pattern in the siRNA 
screen data sets, we identified those genes linked to FOXK1 loci 
that also showed a cell cycle phenotype (arrest at a specific cell cycle 
phase or endoreduplication) after knockdown. Of the 2585 genes 
that showed a cell cycle arrest phenotype in at least one of the four 
genome-wide siRNA screens (Mukherji et al., 2006; Root et al., 
2006; Kittler et al., 2007; Rines et al., 2008), 230 (9%) were linked by 
GCA to a FOXK1 ChIP-seq locus (Supplemental Table S4). Again, 
we found enrichment of genes that give an arrest in S phase but also 
for genes that resulted in an arrest in G2. Of interest, genes that ar-
rest cells in G0/G1 have lower percentage occupancy than genes 
that give an arrest in S, G2, or M phase (Figure 7D).
Those genes associated with FOXK1 ChIP loci that have peak 
expression in G1/S include RUNX1, NPAT, C21orf90, and DDX12, 
and those with peak expression in S phase include TYMS, DHFR, 
ABCC5, EFHC1, MBD4, HIST1H2AC, and HIST1H4H, suggesting 
that FOXK1 contributes to G1- and S-phase gene expression. Genes 
with peak expression in G2 and M phases include TUBB, CDC27, 
GAS6, KIF23 and CEP70. Those associated with FOXK1 ChIP-seq 
loci whose genes gave S-phase arrest in genome-wide siRNA 
screens included HIST1H2B, NPAT, GSDMD, RPS3A, and the E2F 
binding partner TFDP1 (Figure 7E). Four of these genes (DHFR, 
TYMS, GSDMD, and TFDP1) also showed decreased mRNA expres-
sion upon FOXK1 siRNA knockdown (Figure 7G-H). The full data are 
available in Supplemental Tables S3 and S4.
TFDP1 shows a modest 2.6-fold decrease in mRNA expression 
levels after FOXK1 knockdown (Figure 7, G and H). Knockdown of 
TFDP1 by RNAi is known to result in cell cycle arrest (Masuhiro et al., 
2008) and is embryonic lethal when it is knocked out in mice (Kohn 
et al., 2003). Consistent with this finding, our hE2F1 reporter failed 
to oscillate after FOXK1 knockdown. To better resolve the location 
of FOXK1 binding in the TFDP1 promoter, we examined the MACS 
peaks in the two independent ChIP-seq experiments (Figure 7E). 
We found FOXK1-binding loci in the TFDP1 promoter just upstream 
of the TSS and within the second, third, and fourth introns of the 
TFDP1 gene (Figure 7E and Supplemental Figure S4). Each of these 
loci contained multiple FOXK1 consensus motifs as determined by 
MEME. The FOXK1 ChIP-seq locus identified in the promoter by 
MACS is 621 base pairs upstream of its TSS (Figure 7E) and contains 
multiple FOXK1 motifs (Figure 7E).
In an attempt to phenocopy the FOXK1-knockdown phenotype 
with a FOXK1-regulated gene, we knocked down TFDP1 in cells 
expressing the PLK1-Luc reporter. As expected, the loss of TFDP1 
expression ablates G2/M-specific luciferase activity driven by the 
human PLK1 promoter (Supplemental Figure S3). Therefore the loss 
of TFDP1, and potentially multiple other cell cycle–regulated genes 
bound by and responsive to FOXK1, can result in a similar cell cycle 
arrest upon siRNA knockdown.
We also examined DHFR, which shows peak expression in S 
phase and has decreased mRNA levels 72 h after FOXK1 siRNA 
knockdown (Figure 7H). We found a strong FOXK1 binding locus in 
the second intron of the gene (Figure 7F) but no evidence for bind-
ing in the DHFR promoter. Consistent with this result, we found that 
a DHFR promoter–luciferase reporter is not responsive to FOXK1 
overexpression (see later discussion).
The 4329 FOXK1 genomic loci map to 1772 unique human 
genes (most genes were associated with multiple FOXK1 genomic 
loci), of which 1303 genes passed basic quality filtering in our 
FOXK1 siRNA–knockdown DNA microarray analysis. To identify 
genes linked to FOXK1 genomic loci that changed expression 
upon FOXK1 siRNA knockdown, we divided genes into groups 
using idealized expression vectors (see Materials and Methods) 
representing decreased or increased expression in the FOXK1 
siRNA–knockdown time course (Supplemental Figure S5). Exami-
nation of the highest-confidence groups shows that 37% (494 
genes) have a specific decrease in expression after FOXK1 knock-
down relative to mock and 17.5% (228 genes) show an increase in 
expression (Supplemental Figures S5 and S6). Therefore FOXK1 
likely acts as both an activator and a repressor of gene expression, 
depending on context.
Thus we propose that FOXK1 is a key regulator of an expansive 
set of critical cell cycle genes that includes TFDP1, DHFR, TYMS, 
GSDMD, and the replication-dependent histone mRNAs. The elimi-
nation of either TFDP1 or GSDMD results in a G1- or S-phase arrest, 
and loss of either could therefore result in the phenotype we initially 
identified in the LumiCycle assay.
FOXK1 can transcriptionally activate key cell 
cycle–regulated genes
To determine whether FOXK1 can activate target cell cycle promot-
ers identified by ChIP-seq, we determined the ability of FOXK1 
overexpression to affect luciferase activity from reporters driven by 
the GSDMD promoter (GSDMD-Luc, 1000 base pairs upstream of 
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sufficient to drive transcription when placed upstream of the tran-
scription start site.
FOXK1 genomic loci can drive luciferase activity 
and are activated by FOXK1 overexpression
To show that the FOXK1 genomic loci identified in our screen can 
drive transcription of a luciferase reporter and can be further acti-
vated by FOXK1 overexpression, we cloned five of our genomic loci 
that included only the DNA sequence from the intersection, up-
stream of luciferase in the absence of a basal promoter (pGL3-
Basic). These five loci mapped within 3000 base pairs of the TSS for 
the genes TFDP1, RPS6KB1, ACAP3, Parp10, and Cep72. Loci 
ranged in size from 865 (Parp10) to 1097 base pairs (ACAP3) and 
contained one (RPS6KB1 and Parp10), two (TFDP1 and Cep72), or 
three (ACAP3) FOXK1-binding motifs as determined by MEME 
(Supplemental Figure S4). As previously mentioned, TFDP1 is an 
E2F binding partner required for the G1/S transition, RPS6KB1 en-
codes a member of the ribosomal S6 kinase family of serine/threo-
nine kinases that increases protein synthesis and cell proliferation 
(Slattery et al., 2011), ACAP3 (also known as CENTB5) is a relatively 
uncharacterized GTPase regulator associated with neurodegenera-
tive processes (Shubina et al., 2009), Parp10 is poly(ADP-ribose) 
polymerase that is phosphorylated by cdk2 in late G1 to S phase 
(Chou et al., 2006), and Cep72 is a centrosomal protein with a criti-
cal role in forming a bipolar spindle (Oshimori et al., 2009). Thus 
each of these proteins plays important functional roles in the cell 
division cycle.
To determine whether these putative regulatory loci could 
drive expression of luciferase in the absence of a basal promoter 
and whether expression of exogenous FOXK1 could activate or 
repress these reporter constructs, we cotransfected each into 
U2OS cells along with either wt FOXK1 or FOXK1 (H355A). All 
five of the reporters (TFDP1-Luc, RPS6KB1-Luc, ACAP3-Luc, 
Parp10-Luc, and Cep72-luc) resulted in expression of baseline 
luciferase activity in the absence of exogenous FOXK1. Four re-
porters (TFDP1-Luc, RPS6KB1-Luc, ACAP3-Luc, and Cep72-luc) 
showed a significant increase in luciferase activity over 120 h 
when cotransfected with wt FOXK1 but not with FOXK1 (H355A; 
Figure 9). The peak of induction occurred between 48 and 72 h 
posttransfection, and each of the four constructs showed a sig-
nificant (p < 0.05) increase in luciferase activity between wt 
FOXK1 and FOXK1 (H355A; Table 1). The weakest induction was 
observed for Parp10-Luc, which showed a statistically significant 
the TSS), which contains a FOXK1-binding locus and multiple 
FOXK1-binding motifs, or DHFR (DHFR-Luc, 1000 base pairs up-
stream of TSS), which does not have any FOXK1-binding loci in its 
promoter (a locus was detected in the second intron). Both genes 
are cell cycle regulated, and knockdown of GSDMD was shown 
to result in a cell cycle arrest at S phase in a genome-wide siRNA 
screen (Kittler et al., 2007 ). To test whether FOXK1 activates these 
promoters, we overexpressed wild-type (wt) FOXK1 or FOXK1 with 
a mutation in the DNA-binding domain (FOXK1 H355A), which 
served as a negative control (Freddie et al., 2007). Cotransfection of 
wt FOXK1 with GSDMD-Luc resulted in a significant increase in lu-
ciferase activity over time (Figure 8A; p < 0.05), whereas cotransfec-
tion of the DNA-binding-deficient mutant FOXK1 (H355A) showed 
no significant change (Table 1). In contrast, FOXK1 could not acti-
vate DHFR-Luc, which lacked a FOXK1 locus in the promoter, when 
cotransfected with either wt FOXK1 or FOXK1 (H355A; Figure 8B). 
This shows that FOXK1 can activate the transcription of one of its 
targets and demonstrates specificity by not activating the promoter 
of a target gene in which the FOXK1-binding locus identified was 
purely intronic. Finally, a small, 150–base pair intronic locus from 
DHFR containing multiple FOXK1 motifs placed in the promoter 
of pGL3-Basic failed to drive basal luciferase activity or show induc-
tion with expression of exogenous wt FOXK1 (unpublished data), 
suggesting that an intronic FOXK1-binding locus alone is not 
FIGURE 8: Wild-type FOXK1 activates the gasdermin D promoter 
(GSDMD-luc), whereas a mutant FOXK1 does not. (A) Wild-type 
FOXK1 (light line) activates a gasdermin D (GSDMD) promoter, 
whereas a DNA binding–domain mutant version of FOXK1 (dark line) 
does not activate transcription of luciferase. (B) Neither wild-type 
FOXK1 nor mutant FOXK1 (H355A) activates the promoter of DHFR 
that does not have any FOXK1-binding motifs and lacks any 
detectable FOXK1 loci in its promoter. Each line is a representative 
experiment with at least four replicates. Error bars are SE of the 
mean. Time points were binned and averaged in 24-h windows for a 
one-way ANOVA. *p < 0.05; all p values are given in Table 1.
Promoter 
construct 0–24 h 24–48 h 48–72 h 72–96 h 96–120 h
GSDMD 0.599 0.021 0.014 0.019 0.034
DHFR 0.919 0.638 0.400 0.432 0.527
ACAP3 0.012 0.013 0.029 0.041 0.013
Cep72a 0.004 0.003 0.001 0.002 0.063
RPS6KB1 0.645 0.002 0.007 0.016 0.026
TFDP1 0.727 0.003 0.006 0.065 0.099
Parp10 0.764 0.004 0.265 0.782 0.641
Readings were binned and averaged in 24-h windows. One-way ANOVAs 
were calculated for wild-type FOXK1 vs. DNA binding–domain mutant FOXK1 
(H355A) for the quadruplicate samples that were averaged in Figures 8 and 9.
aDue to technical issues, Cep72 was performed in triplicate. Bold indicates 
p < 0.05.
TABLE 1: Luciferase assay p values.
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endogenous FOXM1 activity, a second driven by the human PLK1 
promoter to report the G2/M phase of the cell cycle, and a third 
that reports G1/S through the human E2F1 promoter. These cell 
cycle–controlled DNA elements faithfully report each respective 
phase of the cell cycle in synchronized U2OS cells based on the 
phasing of the luciferase rhythms in relation to the synchronization 
method, protein profiles, and FACS profiles after synchronization. 
In addition, the Forkhead DNA-binding sites in the 6xDB reporter 
can be bound by FOXM1. We used these novel reporters to show 
that targeted reduction of FOXJ3 and FOXK1 expression by siRNA 
in synchronous U2OS cells ablates cell cycle–dependent luciferase 
activity in both reporter cell lines and confirmed the cell cycle phe-
notype by FACS analysis and growth curves.
In U2OS cells, FOXK1 is not cell cycle regulated at the protein 
level (unpublished data). This is not unprecedented, as cyclin-de-
pendent kinases are not cell cycle regulated at the mRNA level 
(Whitfield et al., 2002), but instead their activity is regulated by their 
difference in expression from 24 to 48 h (p = 0.004) but not from 
48 to 72 h (p = 0.265).
Therefore five of the FOXK1-binding loci, including parts of the 
promoter of TFDP1, are sufficient to drive basal expression of lu-
ciferase and can be further activated by overexpression of the wt 
FOXK1. We find no induction when we use the DNA-binding mu-
tant FOXK1 (H355A). In addition, the full promoter of a sixth target, 
GSDMD, which contained a FOXK1 ChIP-seq locus, is also respon-
sive to wt FOXK1 but not FOXK1 (H355A), whereas the promoter of 
DHFR that did not contain a ChIP-seq locus was not responsive to 
wt FOXK1, showing specificity of the effect.
DISCUSSION
Here we described a novel method to follow cell cycle progression 
in live human cells with far greater precision than was previously 
possible and used this to identify novel cell cycle regulators. Three 
luciferase reporter constructs were used—one that monitors 
FIGURE 9: Wild-type FOXK1 but not mutant FOXK1 activates cell cycle promoters that contain FOXK1-binding motifs 
in live cells. FOXK1 (light line) activates the expression of luciferase from the ACAP3 (A), Cep72 (B), RPS6KB1 (C), or 
TFDP1 (D) promoter. Mutant FOXK1 (dark line) does not activate expression of luciferase from these promoters. 
(E) FOXK1 activates expression of the Parp10 promoter between 24 and 48 h posttransfection to a greater extent than 
mutant FOXK1. Each line is a representative experiment with at least three replicates. Error bars are SE of the mean. 
Time points were binned and averaged for every 24 h for a one-way ANOVA. *p < 0.05, **p < 0.01, ***p < 0.005. All 
p values are given in Table 1.
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powerful tool in cancer drug assays. As a result of the assay’s nonde-
structive nature, using real-time luciferase assays will allow screen-
ing of compounds having a limited availability due to cost or origin 
and will also allow for multiple treatments of the same cell popula-
tion in one experiment.
MATERIALS AND METHODS
Cell lines
U2OS cells were passaged at 37°C in a humidity-controlled, CO2-
equilibrated incubator in DMEM (Life Technologies, Grand Island, 
NY) culture medium (CM) containing 10% fetal bovine serum (FBS) 
and 1% penicillin/streptomycin (Pen Strep). All stable lines were pas-
saged in a selection medium (SM) of CM and 1.5 μg/ml puromycin.
Stable U2OS hE2F1, 6xDB, and PLK1 luciferase lines were gener-
ated by cotransfection of a minimal E2F1 promoter driving luciferase 
(Johnson et al., 1994), a construct containing the 6xDB Forkhead 
consensus site (Laoukili et al., 2005), or the human PLK1 promoter 
(S119035, Switchgear Genomics, Menlo Park, CA), using 8 μg of 
plasmid with 2 μg of puromycin-resistant pBABE-puro with FuGENE 
6 (Roche, Indianapolis, IN). Negative control cell lines were pro-
duced with the same protocol and plasmid insertion confirmed via 
PCR of the luciferase open reading frame (5′ATCCAGATCCACAAC-
CTTCG3′; 5′AGAACTGCCTGCGTGAGATT3′).
Cell line synchronization
Thymidine-thymidine synchronizations were performed with U2OS 
cells in 35-mm dishes (Corning, Lowell, MA) at 2 × 104 to 8 × 104 
cells/plate. After 24 h, thymidine was added to a final concentration 
of 2.5 mM. Cells were held in thymidine for 18 h, washed with 1.0 ml 
of prewarmed, CO2-equilibrated, 1× phosphate-buffered saline 
(PBS), followed by the addition of fresh selection media. After growth 
for 8 h, 2.5 mM thymidine was added for 18 h, and cells were again 
washed and released into fresh selection media. Thymidine/nocoda-
zole synchronizations were performed with U2OS cells at 4 × 104 cells/
plate. After 24 h, cells were treated with 2.5 mM thymidine for 18 h, 
washed with 1× PBS once, and released into fresh medium with 
100 ng/ml nocodazole. After 12 h, medium was removed, and float-
ing mitotic cells were collected by centrifugation.The remaining cells 
were washed once with 1× PBS, and floating cells were resuspended 
in fresh medium and replated with the adherent population.
Real-time bioluminescence monitoring
Synchronous U2OS cells were washed with PBS and the SM re-
placed with 2 ml of assay medium (phenol red–free L15 [Life Tech-
nologies], 10% FBS, 1% Pen Strep, 10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid, and 0.1 mM luciferin). Tissue culture 
dishes were sealed with 38 circle #1 glass coverslips and silicone 
grease and transferred to the LumiCycle (Actimetrics, Wilmette, IL) 
at 36°C. Data analysis was performed with the LumiCycle Analysis 
software (Actimetrics). Where indicated, data were baseline sub-
tracted using a 24-h running average. Time zero (t = 0) indicates 
time of release from cell cycle synchronization.
Promoter assays were performed by transfecting U2OS cells with 
250 ng of each plasmid (see later description) using FuGENE 6 (Life 
Technologies) immediately before sealing the dishes and transfer-
ring them to the LumiCycle. Where possible, each promoter 
construct was placed in the LumiCycle so it would use the same 
photomultiplier tube. The p values were calculated using SPSS Sta-
tistics 19 (IBM, Armonk, NY) by performing a one-way analysis of 
variance (ANOVA) comparing the replicate wt FOXK1 transfections 
with the mutant FOXK1 (H355A) transfections. Luciferase readings 
were binned and averaged over each 24-h period.
well-characterized interactions with cyclins (Sherr, 2000). Therefore 
it is entirely plausible that there is a cell cycle phase–specific activa-
tion of FOXJ3 or FOXK1 due to other posttranslational modifica-
tions such as phosphorylation or cell cycle–regulated binding part-
ners. Pointing to a possible role of FOXK1 in the cell cycle, mouse 
Mnf−/− (FoxK1) cells have dysregulated expression of cell cycle 
genes, and Mnf−/− mice are ∼40% smaller than wild-type littermates 
and have impaired muscle repair (Garry et al., 2000).
The ChIP-seq and gene expression data for FOXK1 allow us to 
propose a mechanism for its role in the cell cycle. Our data show 
that FOXK1 is required for the activation of an expansive set of cell 
cycle–regulated genes, many of which, when knocked out in pub-
lished siRNA screens, result in a cell cycle arrest; these include 
TFDP1 and GSDMD. Thus there are numerous FOXK1 targets, any 
one of which might result in a cell cycle arrest when knocked out. 
Consistent with this, our attempts to rescue the FOXK1 cell cycle 
arrest phenotype by overexpressing TFDP1 failed to restore cell cy-
cle–regulated gene expression (unpublished data). This result sup-
ports the idea that a combinatorial effect resulting from the loss of 
FOXK1 that includes multiple cell cycle genes results in the cell cycle 
arrest we observe in our screen.
Earlier publications in different model systems showed that 
FOXK1, when in a complex with the MADS-box SRF transcription 
factor or Sin3B, functions as a repressor of promoter activity (Yang 
et al., 2000; Freddie et al., 2007). Of interest, SRF contains a FOXK1-
binding locus downstream of the TTS and shows decreased expres-
sion upon FOXK1 siRNA knockdown (Supplemental Figure S6). The 
repressive activity of FOXK1 when complexed with SRF is in contrast 
with the data presented here, which demonstrate that in the subset 
of genes analyzed, FOXK1 is an activator of transcriptional activity 
(Figures 8 and 9). It is likely that FOXK1 can be either an activator or 
a repressor, depending on promoter context and cell type (U2OS vs. 
RD18 or 293), and this is supported by our analysis of genes associ-
ated with FOXK1 genomic loci in the FOXK1 siRNA–knockdown 
time course, which shows genes with increased expression (e.g., are 
likely repressed by FOXK1) and decreased expression (e.g., FOXK1 
activated as shown here). A simple mechanism for this duality may 
lie in the FOXK1 cofactors such as SRF, which impart a repressive 
function to the complex, whereas others result in activation. Of 
interest, FOXK1 does not appear to function as a pioneer factor, as 
it requires SRF for efficient recruitment to the α-actin promoter or 
the synthetic CArG construct (Freddie et al., 2007). This would imply 
that FOXK1 is more dependent on cofactors than other FOX genes, 
and its roles in gene expression may be much more varied, depend-
ing on complex composition.
Proposing a mechanism for the FOXJ3 cell cycle defect is more 
challenging, as there are no ChIP-seq data available, and current 
antibodies against FOXJ3 were insufficient for this purpose. The 
genes that cluster with FOXJ3 suggest that it may be involved in 
regulating a network of zinc finger–binding proteins that may affect 
gene expression themselves. What role these may have in cell cycle 
progression is unclear.
These results demonstrate that real-time luciferase assays can 
greatly enhance the precision and reduce the cost associated with 
the evaluation of potential novel regulators of cell cycle gene ex-
pression. This methodology will also facilitate development of syn-
chronization protocols, as the need for sample collections at regular 
intervals over multiple cell cycles is not required. Luciferase monitor-
ing is more cost-effective than traditional time-course experiments, 
fewer samples are required to achieve statistically significant data, 
and multiple conditions can be tested with replicates at a single 
time. With further refining, this technology may also prove to be a 
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protocol. Primers were obtained from Life Technologies and were 
as follows: 6xDB primer 1 (forward, ACGCTGTTGACGCTGTTAAG; 
reverse, CGAATTCGAACACGCAGAT), 6Xdb primer 2 (forward, 
CCACAC GCGTCACCTTAATA; reverse, GCCCAGCGTCTTGT-
CATT), and GAPDH (forward, CAATTCCCCATCTCAGTCGT; reverse, 
TAGTAG CCGGGCCCTACTTT).
FOXK1 ChIP-seq was carried out as previously described (Lupien 
et al., 2008) using antibodies sc-133592 (G22) and sc-134550 (H140) 
against FOXK1 (Santa Cruz Biotechnology). Briefly, HeLa cells were 
fixed with 1% formaldehyde before the DNA was sonicated to a 
fragment length of 200–600 base pairs with a Bioruptor (Diagen-
ode, Sparta, NJ). Antibodies were bound to a mix of protein A and 
protein G Dynabeads (Life Technologies) before an 18-h incubation 
at 4°C with the fragmented DNA. DNA was washed and cross-links 
reversed before purification with a QIAquick PCR purification kit 
(Qiagen, Valencia, CA). DNA concentrations were measured using 
Quant-iT PicoGreen (Life Technologies). A library was constructed 
from the bound fragments per manufacturer’s protocols, and the 
DNA fragments from each independent ChIP were sequenced inde-
pendently at the High Throughput Sequencing Facility, University of 
North Carolina at Chapel Hill (UNC; Chapel Hill, NC), using an Illu-
mina Genome Analyzer II. Fastq files obtained from the Genome 
Analyzer for each run were mapped to human genome using Bowtie 
software (version 0.12.5), using the “best” flag to constrain reported 
alignments to those with the fewest mismatches and best read qual-
ity. ChIP-seq of FOXK1 using AB G22 resulted in 58 million mapped 
sequence reads (2.1 million unmapped), and ChIP-seq using 
AB134550 resulted in 65 million mapped reads (2.2 million un-
mapped, Human Genome build Hg19). Enriched peaks were identi-
fied independently in each data set using MACS version 1.3.7 
(Zhang et al., 2008; mfold 15, p < 0.001), which resulted in 7513 
peaks in AB G22 and 6225 peaks in AB1344550. As a conservative 
estimate of FOXK1 binding, we analyzed the intersection of the se-
quences under the peaks found in both experiments, resulting in 
4329 shared FOXK1-binding loci. We determined the distribution 
of these 4329 shared FOXK1-binding loci in the genome using the 
Cis-regulatory Element Annotation System (CEAS; http://liulab.dfci 
.harvard.edu/CEAS; Zhang et al., 2008) implemented in Cistrome 
(www.cistrome.com). The full data are available from the Gene 
Expression Omnibus (GEO) repository GSE39138.
Identification of cis-acting regulatory elements
The 4329 shared loci were analyzed for cis-acting regulatory motifs. 
RepeatMasker Open-3.0. (www.repeatmasker.org) was used to screen 
input DNA for repeats and generate a modified version of the query 
sequence with masked repeats (replaced with N’s). Sequence com-
parisons in RepeatMasker were performed by default search engine 
“cross_match” and were run with “–nolow” parameter. To analyze 
masked ChIPseq data and discover significant motifs with high simi-
larity to FOXK1 site and their potential partners, we used MEME Suite 
(Bailey et al., 2009). Specifically, we analyzed sequences resulting 
from the intersection of the MACS peaks from the two experiments 
by MEME-ChIP (Machanick and Bailey, 2011), which is designed spe-
cifically for motif analysis in large ChIP-seq data sets. MEME-ChIP 
was run via Web server with default settings except for the following: 
motif distribution, any number of repetitions; optimum motif width, 
6–10 base pairs; maximum number of motifs to find, 10.
To identify the best matches to known FOXK1 sites among mo-
tifs predicted by MEME-ChIP, we used STAMP (Mahony and Benos, 
2007). We compared the output from MEME-ChIP to a manually 
constructed database that contained a position-weight matrix that 
represented the published FOXK1 motif (TAAACA; Tsai et al., 2006). 
Plasmids
DHFR (S101166), PLK1 (S119035), and GSDMD (S112693) were 
purchased from Switchgear Genomics. The FOXK1 (2256) and 
DNA-binding mutant FOXK1 (2265) (Freddie et al., 2007) con-
structs were gifts from A. Sharrocks. 6xDB (Furuyama et al., 2000; 
Laoukili et al., 2005) was a gift from R. Medema, and the minimal 
hE2F promoter construct (Johnson et al., 1994) was a gift from 
W. D. Cress. FOXM1-ER was subcloned from an ER fragment (gift 
from M. Cole) and FOXM1-pBABE-puro, which was cloned from 
human cDNA. All plasmids were sequenced to confirm that there 
were no errors (Molecular Biology and Proteomics Core Facility, 
Dartmouth College).
FOXK1 target promoters were cloned based on the ChIP-seq loci 
as determined by MACS. Primers were designed to flank any FOXK1 
motifs and to provide an amplicon between 800 and 1000 base 
pairs long (Primer 3; Rozen and Skaletsky, 2000). DNA fragments 
were amplified by PCR and cloned into Zero Blunt TOPO (Life 
Technologies), and then they were subcloned into the MCS of pGL3-
basic (Promega, Madison, WI) using standard methods. All inserts 
were sequenced to confirm their identity (Molecular Biology and 
Proteomics Core Facility, Dartmouth College).
siRNA transfections
Cells were transfected with siRNA (100 nM) using Oligofectamine 
(Life Technologies). Bioluminescence assays were performed as de-
scribed, except that siRNA transfection began 24 h before the first 
thymidine arrest (Supplemental Figure S1B). RNA was collected 
48 h after transfection to measure knockdown efficiency of each 
siRNA by Taqman quantitative RT-PCR. All siRNAs were obtained 
from Dharmacon/Thermo Fisher Scientific (Lafayette, CO): FOXJ3 
(#1, GGGAAAGGUUUAAGAGAAUUU; #2, GUAGGAAACUGAAA-
GG AAAUU); FOXK1 (#1, GAGCAGUGGUUCUUGGAAAUU; #2, 
AGAACAAUGCCAAGUGAAAUU); FOXM1 (GGACCACUUUCCCU-
ACUUU; Wang et al., 2005); and siGENOME SMARTpool, human 
TFDP1 (7027). Human siGENOME Non-Targeting siRNA #2 was 
used as a negative control.
Western blot analysis
Antibodies to FoxM1 C-20 (1:500), cyclin B1 (H-433; 1:2000), and 
E2F1 (C-20; 1:500) were purchased from Santa Cruz Biotechnology 
(Santa Cruz, CA), anti–glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) was purchased from American Research Products (Belmont, 
MA), and anti-FOXK1 (ab18196) was purchased from Abcam (Cam-
bridge, MA). Protein was collected from each plate in SDS–PAGE 
sample buffer. Western blots were run following standard protocols.
Real-time PCR
All real-time PCRs were performed with an Applied Biosystems 
(Foster City, CA) 7500 Fast Real Time PCR system using TaqMan 
Fast Universal PCR Master Mix (Applied Biosystems), TaqMan 
Gene Expression Assays, and 5 ng of cDNA template according 
to manufacturer’s instructions in triplicate, except that all reaction 
volumes were reduced by one-half. Primers used were as follows: 
FOXM1, Hs00153543_m1; FOXJ3, Hs00208978_m1; FOXK1, 
Hs01595620_m1; and GAPDH, 4352934E. All primers were pur-
chased from Applied Biosystems. Real-time data were analyzed 
using the 2−ΔΔCT method (Livak and Schmittgen 2001), using 
GAPDH as a control.
ChIP-seq
FOXM1 chromatin immunoprecipitations were performed with 
Upstate Biotechnology/Millipore (Billerica, MA) ChIP assay kit 
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gene to a bin, we computed the dot product of the normalized ex-
pression data for each gene to each of the eight possible ideal pat-
terns to generate an “ideal pattern” score. We ordered each bin by 
the “ideal pattern” score and displayed the data using Java TreeView 
(Supplemental Figure S5).
FACS determination of cell cycle phase
Cell synchrony was monitored by flow cytometry of propidium io-
dide–stained cells (Whitfield et al., 2002). Percentage of cells in each 
cell cycle phase was determined with FlowJo, version 7.5 (Tree Star, 
Ashland, OR).
Growth curve
U2OS cells expressing the E2F1 construct were plated at a density 
of 6 × 106 cells/well in 12-well dishes. After 24 h of growth, 100 nM 
siRNA was transfected with Oligofectamine, and three wells were 
counted using trypan blue for each time point. 
The full data figures in both red/green and blue/yellow formats are 
available from a website maintained by the authors at http://
whitfieldlab.dartmouth.edu/lumicycle.
A motif was considered to be a match to a FOXK1 site if STAMP 
E value was <1 × 10−4. STAMP was run with default settings. To find 
significant spacing patterns between FOXK1 matches and other 
motifs predicted by MEME-ChIP, we used SpaMo (Whitington et al., 
2011). SpaMo was run in command line mode with the following 
parameters: “-margin 100 -shared 1.” Motifs that formed significant 
spacing patterns with FOXK1 matches were run via STAMP against 
TRANSFAC, version 11.3 (Matys et al., 2003), to identify potential 
FOXK1 cofactors. To extract all instances of each individual motif, 
we used FIMO in command line mode with the modified p value 
output threshold of 1 × 10−3.
RNA isolation and microarray hybridization
Asynchronous U2OS cells were transfected with siRNAs targeting 
FOXJ3 or FOXK1 with Oligofectamine, following the manufac-
turer’s protocols. Experiments were performed in a time-course 
design. Three time-zero points were collected from untransfected 
cells. Time points were then harvested in parallel from the mock-
transfected and the FOXJ3 and FOXK1 siRNA–transfected cells at 
12, 24, 48, and 72 h after transfection. Cellular RNA was isolated 
using the RNeasy Plus Kit (Qiagen). Total RNA (200 ng) was ampli-
fied using the Quick-Amp Labeling Kit (Agilent Technologies, 
Santa Clara, CA) and hybridized to Agilent Technologies Whole 
Human Genome Oligonucleotide arrays (4 × 44k) following the 
manufacturer’s protocol, except for the labeling reaction, for 
which volumes were reduced by half. Microarrays were scanned 
using a GenePix 4000B scanner (Molecular Devices, Sunnyvale, 
CA). Spot pixel intensities were determined by the GenePix Pro 
5.1 software. Poor-quality spots were manually flagged and 
excluded from further analysis. Arrays were stored in the UNC 
Microarray Database.
Gene expression data were retrieved for each microarray from 
the UNC microarray database. Only spots with intensity over back-
ground of >1.5 were used for further analysis. Genes missing >20% 
of their data were excluded from further analysis; only genes with 
three observations with a log2 absolute value of ≥1.1 (a 2.14-fold 
change) across all three time-course experiments were selected. 
Gene selection and hierarchical clustering were performed using 
Cluster 3.0 (Eisen et al., 1998). The 24-h time point for the FOXK1 
siRNA was excluded from the analysis due to a technical failure. 
Data were zero transformed by normalizing each time course to the 
average of the three zero time points. Data were visualized using 
Java TreeView software (Saldanha, 2004).
Functional annotation of gene clusters was performed using 
DAVID (Dennis et al., 2003; Huang da et al., 2009) with the following 
categories: cog_ontology, sp_pir_keywords, up_seq_feature, got-
erm_bp_fat, BBID, Biocarta, KEGG_pathway. Only categories with 
p < 0.05 are shown in Supplemental Table S1. The p values cor-
rected for multiple hypothesis testing are also provided.
To identify genes associated with FOXK1 ChIP-seq loci that also 
showed a change in expression upon FOXK1 knockdown, we nor-
malized the expression values of genes associated with FOXK1 loci 
(as determined by CEAS) to a maximum value between −1 and 1. 
We then constructed “ideal patterns” of expression, where perfect 
induction would have a 1 for each time point, perfect repression 
would be signified by −1, and unregulated would be indicated by 0. 
Because there are three expression categories and two treatment 
conditions, we set up 23 = 8 bins, one per pattern. For example, the 
“ideal pattern” for a gene that is repressed after FOXK1 siRNA 
treatment and unregulated after mock treatment is four zeros fol-
lowed by four ones (00001111). We then normalized the ideal pat-
terns in the same way as the gene expression data. To assign each 
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